ASSEMBLY, No. 931

STATE OF NEW JERSEY

214th LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2010 SESSION

 


 

Sponsored by:

Assemblywoman  VALERIE VAINIERI HUTTLE

District 37 (Bergen)

 

 

 

 

SYNOPSIS

     Requires Medicaid, NJ FamilyCare and SHBP to cover cost of HPV vaccine.

 

CURRENT VERSION OF TEXT

     Introduced Pending Technical Review by Legislative Counsel

  


An Act concerning insurance coverage for HPV vaccine and supplementing Titles 30 and 52 of the Revised Statutes.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    The Medicaid program established pursuant to P.L.1968, c.413 (C.30:4D-1 et seq.) and the NJ FamilyCare Program established pursuant to P.L.2005, c.156 (C.30:4J-8 et al.) shall provide coverage for expenses incurred for a vaccination against the human papillomavirus (HPV) that is approved for marketing by the federal Food and Drug Administration.

 

     2.    The State Health Benefits Commission shall ensure that every contract purchased by the commission, on or after the effective date of this act, that provides hospital or medical expense benefits shall provide coverage for expenses incurred for a vaccination against the human papillomavirus (HPV) that is approved for marketing by the federal Food and Drug Administration.

     The benefits shall be provided to the same extent as for any other medical condition under the program.

 

     3.    This act shall take effect on the 90th day after enactment, and shall apply to policies or contracts issued or renewed on or after the effective date.

 

 

STATEMENT

 

     This bill requires that the State Medicaid and NJ FamilyCare programs, and the State Health Benefits Program provide coverage for a vaccination against the human papillomavirus (HPV) that is approved for marketing by the federal Food and Drug Administration.

     HPV is the most common sexually-transmitted infection in this country.  The Centers for Disease Control and Prevention estimates that about 6.2 million Americans become infected with genital HPV each year, and that over 50% of all sexually active men and women become infected at some time in their lives.  For most women, the body's own defense system will clear the virus and infected women will not develop related health problems; however, some types of HPV can cause abnormal cells on the lining of the cervix that may become cancerous.  Other types of HPV can cause genital warts.